Takeda joins BaseLaunch to boost early-stage biotech ventures in Europe

BaseLaunch has supported 27 biotech companies across multiple modalities and indications

BaseLaunch announces a new partnership with AbbVie

Further strengthens BaseLaunch's global pharma industry partnerships

Pigeon Singapore, LyondellBasell collaborate to incorporate bio-circular plastic in nursing bottles

The LyondellBasell CirculenRenew polymers are made from renewable feedstocks derived from bio-based wastes

LyondellBasell awarded the 2023 Global Medical Plastics Company of the year

LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions

M. Holland join hands with LyondellBasell to distribute purell medical grade resins

New material distribution will serve medical device and pharmaceutical packaging manufacturers.

Roche’s investigational obesity drug CT-388 delivers dramatic weight loss in Phase II trial

The Phase III programme, Enith1 and Enith2, is expected to launch this quarter

GSK reports breakthrough results in chronic hepatitis B trials

Ascletis Pharma gets FDA nod for Phase II diabetes trial of oral GLP-1 drug

The trial’s primary endpoint is the mean change in HbA1c from baseline, while secondary endpoints include changes in fasting blood glucose, body weight, and overall safety

Ultragenyx’s Setrusumab falls short in Phase 3 osteogenesis imperfecta trials

The trials did not show a statistically significant reduction in annualized clinical fracture rates compared to placebo or bisphosphonates

Biohaven reports Phase 2 depression trial results

Despite some promising subgroup signals, the company indicated it will not pursue further psychiatric trials